Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors'

导出原文传递

翻译打印收藏纠错

作者： Heinzerling, Lucie ^[1] ; La Rosee, Paul ^[2] ; Gutzmer, Ralf ^[3] ; Kramer, Rafaela ^[4] ; Keller-Stanislawski, Brigitte ^[5] ; Zierold, Sarah ; Mentzer, Dirk

作者单位： Paul Ehrlich Inst, Langen, Germany ^[1] Palliat Med Schwarzwald Baar Klinikum, Med Klin Onkol Hamatol Immunol Infektiol 2, Villingen ^[2] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Dermatol & Allergy, Munich, Germany ^[3] Friedrich Alexander Univ Erlangen Nurnberg FAU, Univ Klinikum Erlangen, Dept Dermatol, Erlangen ^[4] Ruhr Univ Bochum Campus, Dept Dermatol, Muhlenkreiskliniken AoR, Minden, Germany ^[5]

发布时间 2021-10-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

European journal of cancer

2021年153卷

272-273页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors'

European journal of cancer

相似文献

European journal of cancer

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Response to letter entitled: 'Re: Hematological immune related adverse events after treatment with immune checkpoint inhibitors'

European journal of cancer

相似文献

European journal of cancer

相关期刊

检索历史清除